AT327413B - METHOD OF MANUFACTURING NEW 15ALPHA, 16ALPHA-METHYLENE-4-OSTRENE-17BETA-OLEN - Google Patents

METHOD OF MANUFACTURING NEW 15ALPHA, 16ALPHA-METHYLENE-4-OSTRENE-17BETA-OLEN

Info

Publication number
AT327413B
AT327413B AT112473A AT112473A AT327413B AT 327413 B AT327413 B AT 327413B AT 112473 A AT112473 A AT 112473A AT 112473 A AT112473 A AT 112473A AT 327413 B AT327413 B AT 327413B
Authority
AT
Austria
Prior art keywords
ostrene
15alpha
16alpha
olen
17beta
Prior art date
Application number
AT112473A
Other languages
German (de)
Other versions
ATA112473A (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Priority to AT1039174A priority Critical patent/AT339514B/en
Publication of ATA112473A publication Critical patent/ATA112473A/en
Application granted granted Critical
Publication of AT327413B publication Critical patent/AT327413B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT112473A 1972-02-11 1973-02-08 METHOD OF MANUFACTURING NEW 15ALPHA, 16ALPHA-METHYLENE-4-OSTRENE-17BETA-OLEN AT327413B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT1039174A AT339514B (en) 1972-02-11 1974-12-30 METHOD FOR MANUFACTURING NEW 15ALFA, 16ALFA-METHYLENE-4-OSTRENE-17BETA-OLEN

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2207421A DE2207421C3 (en) 1972-02-11 1972-02-11 15?, 16? -Methylene-4-oestrene-17? -ols or acylates, processes for their production and medicaments containing them

Publications (2)

Publication Number Publication Date
ATA112473A ATA112473A (en) 1975-04-15
AT327413B true AT327413B (en) 1976-01-26

Family

ID=5836211

Family Applications (1)

Application Number Title Priority Date Filing Date
AT112473A AT327413B (en) 1972-02-11 1973-02-08 METHOD OF MANUFACTURING NEW 15ALPHA, 16ALPHA-METHYLENE-4-OSTRENE-17BETA-OLEN

Country Status (29)

Country Link
JP (1) JPS5829317B2 (en)
KR (1) KR780000156B1 (en)
AT (1) AT327413B (en)
AU (1) AU467306B2 (en)
BE (1) BE795241A (en)
CA (1) CA997753A (en)
CH (2) CH593995A5 (en)
CS (1) CS193019B2 (en)
DD (1) DD102379A5 (en)
DE (1) DE2207421C3 (en)
DK (1) DK131037B (en)
EG (1) EG10914A (en)
ES (1) ES410933A1 (en)
FI (1) FI52225C (en)
FR (1) FR2181719B1 (en)
GB (1) GB1425636A (en)
GR (1) GR63160B (en)
HU (1) HU165253B (en)
IE (1) IE37266B1 (en)
IL (1) IL41506A (en)
NL (1) NL177217C (en)
NO (2) NO140304C (en)
PH (1) PH9370A (en)
PL (1) PL81084B1 (en)
RO (1) RO73527A (en)
SE (3) SE403781B (en)
SU (1) SU513628A3 (en)
YU (1) YU35035B (en)
ZA (1) ZA73944B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007027637A1 (en) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17β-cyano-19-nor-androst-4-ene derivative, its use and the derivative-containing drug
DE102007027636A1 (en) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17β-Cyano-18α-homo-19-nor-androst-4-ene derivative, its use and the derivative-containing drug

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT274653B (en) * 1966-11-10 1969-09-25 Alexander Schoeller & Co Kg Stackable, rectangular, closed plastic transport container for fine-grained bulk goods and liquids

Also Published As

Publication number Publication date
CH590883A5 (en) 1977-08-31
YU24373A (en) 1979-12-31
KR780000156B1 (en) 1978-05-02
AU5207673A (en) 1974-08-15
ES410933A1 (en) 1976-03-01
IE37266L (en) 1973-08-11
RO73527A (en) 1982-02-01
EG10914A (en) 1976-09-30
SE409329B (en) 1979-08-13
GR63160B (en) 1979-09-25
NO143065B (en) 1980-09-01
SE7514513L (en) 1975-12-22
DD102379A5 (en) 1973-12-12
SE7713896L (en) 1977-12-07
YU35035B (en) 1980-06-30
CH593995A5 (en) 1977-12-30
CA997753A (en) 1976-09-28
AU467306B2 (en) 1975-11-27
DK131037C (en) 1975-10-20
ZA73944B (en) 1973-11-28
NO143065C (en) 1980-12-10
NO140304C (en) 1979-08-08
SE403781B (en) 1978-09-04
ATA112473A (en) 1975-04-15
IL41506A0 (en) 1973-04-30
IE37266B1 (en) 1977-06-08
DK131037B (en) 1975-05-20
PL81084B1 (en) 1975-08-30
NL7301974A (en) 1973-08-14
NO140304B (en) 1979-04-30
JPS5829317B2 (en) 1983-06-22
DE2207421A1 (en) 1973-08-16
SE426834B (en) 1983-02-14
CS193019B2 (en) 1979-09-17
NO782754L (en) 1973-08-14
NL177217B (en) 1985-03-18
FR2181719B1 (en) 1975-11-21
DE2207421B2 (en) 1980-07-24
FI52225B (en) 1977-03-31
IL41506A (en) 1976-07-30
HU165253B (en) 1974-07-27
GB1425636A (en) 1976-02-18
PH9370A (en) 1975-10-22
NL177217C (en) 1985-08-16
FR2181719A1 (en) 1973-12-07
SU513628A3 (en) 1976-05-05
DE2207421C3 (en) 1981-05-07
BE795241A (en) 1973-08-09
JPS4886856A (en) 1973-11-15
FI52225C (en) 1977-07-11

Similar Documents

Publication Publication Date Title
AT327181B (en) METHOD FOR MANUFACTURING NEW PHENYLINDANESTERS
AT329203B (en) METHOD FOR PRODUCING NEW HEPTAPEPTIDS
ATA583473A (en) METHOD FOR PRODUCING NEW SUFONAMIDODIPHENYLATHERS
ATA993573A (en) PROCESS FOR MANUFACTURING NEW CEPHALOSPORINATHERS
AT329045B (en) PROCESS FOR MANUFACTURING NEW BASIC SUBSTITUTED INDANDERIVATIVES
AT325605B (en) PROCESS FOR MANUFACTURING NEW ALPHA-PHENYLINDOLDERIVATIVES
ATA770674A (en) METHOD OF MANUFACTURING NEW PENICILLINES
AT330955B (en) PROCESS FOR MANUFACTURING NEW BETA-LACTAMEN
AT325203B (en) METHOD OF MANUFACTURING NEW PENICILLINES
AT329177B (en) METHOD OF MANUFACTURING NEW PENICILLINES
AT325767B (en) METHOD OF MANUFACTURING NEW PENICILLINES
AT326268B (en) METHOD OF MANUFACTURING NEW PENICILLINES
AT328096B (en) METHOD OF MANUFACTURING NEW N (HETEROARYLMETHYL) -7ALPHA-ACYL-6,14-ENDOATHENO-TETRAHYDRO-NORORIPAVINES AND -THEBAINES
AT331805B (en) PROCESS FOR MANUFACTURING NEW TRIAZINOBENZIMIDAZOLES
AT327213B (en) PROCESS FOR MANUFACTURING NEW LACTAMEN
AT324561B (en) METHOD OF MANUFACTURING NEW PENICILLINES
AT327413B (en) METHOD OF MANUFACTURING NEW 15ALPHA, 16ALPHA-METHYLENE-4-OSTRENE-17BETA-OLEN
AT340069B (en) METHOD OF MANUFACTURING NEW PROSTAGLANDINES
AT326841B (en) METHOD FOR PRODUCING NEW 15ALFA, 16ALFA-METHYLENE-4-PREGNENES
AT334879B (en) METHOD FOR MANUFACTURING NEW ARYLATHERS
AT333740B (en) PROCESS FOR MANUFACTURING NEW INDANDERIVATIVES
AT338229B (en) METHOD FOR MANUFACTURING NEW ALDEHYDOLACTONE
AT331971B (en) PROCESS FOR MANUFACTURING NEW 3-MONOESTERS OF ROSAMICIN
AT330356B (en) METHOD OF MANUFACTURING NEW PENICILLINES
ATA967374A (en) METHOD OF MANUFACTURING NEW OXAPROSTAGLANDINES

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
UEP Publication of translation of european patent specification